Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1988 Apr;59(4):403–410. doi: 10.1136/hrt.59.4.403

Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction.

L J Walker 1, G MacKenzie 1, A A Adgey 1
PMCID: PMC1216484  PMID: 3285877

Abstract

In a double blind placebo controlled trial, 434 patients with suspected myocardial infarction were randomised to treatment with nifedipine (n = 217) or placebo (n = 217) within six hours from the onset of chest pain. During the treatment period of 48 hours, a 10 mg capsule containing nifedipine or placebo was given sublingually every four hours for 24 hours, then orally every four hours for the next 24 hours. Acute myocardial infarction was confirmed in 295 patients (146 in the nifedipine group and 149 in the placebo group). The median delay time to intervention with nifedipine in patients with acute myocardial infarction was 111 minutes. Infarct size was assessed by the estimation of release of creatine kinase isoenzyme MB and creatine kinase from blood samples taken every four hours for 48 hours. The total mean (SEM) creatine kinase MB released was 406.4 (27.2) IU/l in the nifedipine group and 345.7 (20.5) IU/l in the placebo group. Total mean (SEM) creatine kinase released was 2749.6 (165.1) IU/l in the nifedipine group and 2698.4 (145.9) IU/l in the placebo group. In hospital mortality was similar for both the nifedipine and placebo groups (6.6% and 5.8% respectively). Treatment with nifedipine in the early phase of acute myocardial infarction seems to have no effect on enzymatically measured infarct size.

Full text

PDF
403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alonso D. R., Scheidt S., Post M., Killip T. Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations. Circulation. 1973 Sep;48(3):588–596. doi: 10.1161/01.cir.48.3.588. [DOI] [PubMed] [Google Scholar]
  2. Blanke H., von Hardenberg D., Cohen M., Kaiser H., Karsch K. R., Holt J., Smith H., Jr, Rentrop P. Patterns of creatine kinase release during acute myocardial infarction after nonsurgical reperfusion: comparison with conventional treatment and correlation with infarct size. J Am Coll Cardiol. 1984 Mar;3(3):675–680. doi: 10.1016/s0735-1097(84)80242-9. [DOI] [PubMed] [Google Scholar]
  3. Branagan J. P., Walsh K., Kelly P., Collins W. C., McCafferty D., Walsh M. J. Effect of early treatment with nifedipine in suspected acute myocardial infarction. Eur Heart J. 1986 Oct;7(10):859–865. doi: 10.1093/oxfordjournals.eurheartj.a061972. [DOI] [PubMed] [Google Scholar]
  4. Clark R. E., Christlieb I. Y., Henry P. D., Fischer A. E., Nora J. D., Williamson J. R., Sobel B. E. Nifedipine: a myocardial protective agent. Am J Cardiol. 1979 Oct 22;44(5):825–831. doi: 10.1016/0002-9149(79)90204-2. [DOI] [PubMed] [Google Scholar]
  5. Gordon G. D., Mabin T. A., Isaacs S., Lloyd E. A., Eichler H. G., Opie L. H. Hemodynamic effects of sublingual nifedipine in acute myocardial infarction. Am J Cardiol. 1984 May 1;53(9):1228–1232. doi: 10.1016/0002-9149(84)90069-9. [DOI] [PubMed] [Google Scholar]
  6. Grande P., Hansen B. F., Christiansen C., Naestoft J. Acute myocardial infarct size estimated by serum CK-MB determinations: clinical accuracy and prognostic relevance utilizing a practical modification of the isoenzyme approach. Am Heart J. 1981 May;101(5):582–586. doi: 10.1016/0002-8703(81)90224-6. [DOI] [PubMed] [Google Scholar]
  7. Hackel D. B., Reimer K. A., Ideker R. E., Mikat E. M., Hartwell T. D., Parker C. B., Braunwald E. B., Buja M., Gold H. K., Jaffe A. S. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation. 1984 Nov;70(5):824–835. doi: 10.1161/01.cir.70.5.824. [DOI] [PubMed] [Google Scholar]
  8. Harnarayan C., Bennett M. A., Pentecost B. L., Brewer D. B. Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J. 1970 Nov;32(6):728–732. doi: 10.1136/hrt.32.6.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henry P. D., Shuchleib R., Borda L. J., Roberts R., Williamson J. R., Sobel B. E. Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res. 1978 Sep;43(3):372–380. doi: 10.1161/01.res.43.3.372. [DOI] [PubMed] [Google Scholar]
  10. Melin J. A., Becker L. C., Hutchins G. M. Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog. Circulation. 1984 Jan;69(1):131–141. doi: 10.1161/01.cir.69.1.131. [DOI] [PubMed] [Google Scholar]
  11. Muller J. E., Morrison J., Stone P. H., Rude R. E., Rosner B., Roberts R., Pearle D. L., Turi Z. G., Schneider J. F., Serfas D. H. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation. 1984 Apr;69(4):740–747. doi: 10.1161/01.cir.69.4.740. [DOI] [PubMed] [Google Scholar]
  12. Norris R. M., Whitlock R. M., Barratt-Boyes C., Small C. W. Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction. Circulation. 1975 Apr;51(4):614–620. doi: 10.1161/01.cir.51.4.614. [DOI] [PubMed] [Google Scholar]
  13. Page D. L., Caulfield J. B., Kastor J. A., DeSanctis R. W., Sanders C. A. Myocardial changes associated with cardiogenic shock. N Engl J Med. 1971 Jul 15;285(3):133–137. doi: 10.1056/NEJM197107152850301. [DOI] [PubMed] [Google Scholar]
  14. Selwyn A. P., Welman E., Fox K., Horlock P., Pratt T., Klein M. The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs. Circ Res. 1979 Jan;44(1):16–23. doi: 10.1161/01.res.44.1.16. [DOI] [PubMed] [Google Scholar]
  15. Sirnes P. A., Overskeid K., Pedersen T. R., Bathen J., Drivenes A., Frøland G. S., Kjekshus J. K., Landmark K., Rokseth R., Sirnes K. E. Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial. Circulation. 1984 Oct;70(4):638–644. doi: 10.1161/01.cir.70.4.638. [DOI] [PubMed] [Google Scholar]
  16. Welman E., Carroll B. J., Lawson J. S., Selwyn A. P., Fox K. M. Effects of nifedipine on creatine kinase release during myocardial ischemia in dogs. Eur J Cardiol. 1978 Jul;7(5-6):379–389. [PubMed] [Google Scholar]
  17. Wilcox R. G., Hampton J. R., Banks D. C., Birkhead J. S., Brooksby I. A., Burns-Cox C. J., Hayes M. J., Joy M. D., Malcolm A. D., Mather H. G. Trial of early nifedipine in acute myocardial infarction: the Trent study. Br Med J (Clin Res Ed) 1986 Nov 8;293(6556):1204–1208. doi: 10.1136/bmj.293.6556.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yoshida S., Downey J. M., Friedman F. R., Chambers D. E., Hearse D. J., Yellon D. M. Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs. Basic Res Cardiol. 1985 Jan-Feb;80(1):76–87. doi: 10.1007/BF01906746. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES